Send feedback

MTMR2 p.Pro80=

c.240A>C · rs201920176 · VCV414070

Benign/Likely benign Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 5 submitters
gnomAD v4.1
Rare
rare (popmax 0.491%, sas)
Conditions
4
Inborn genetic diseases

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -0.072GERP -1.5, phastCons 0.89
Overall
CADD9.652PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.491% South Asian · 447/91,080 alleles
Filtering AF 0.453% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.438%
Overall 0.0291% 470/1,613,916 alleles · rare
Ancestry group Frequency 1 in
South Asiangrpmax 0.491% 204
Middle Eastern 0.0495% 2,020
Remaining individualsnot grpmax-eligible 0.0208% 4,808
Admixed American 0.00333% 30,005
European (non-Finnish) 0.000424% 235,959

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MTMR2
Protein
p.Pro80=
Coding
c.240A>C
MANE Select
NM_016156
dbSNP
rs201920176
Type
single nucleotide variant
Location
chr11:95865623 (GRCh38)
Gene constraint
LOEUF 0.9 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 89.44 · 5 PDB
Residue 80
the gram domain
Full MTMR2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mtmr2-p-pro80 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown